Business / Finance

RSS

Merck board approves additional $5 billion share repurchase program

Merck, known as MSD outside the United States and Canada, today announced that its Board of Directors has approved additional purchases of up to $5 billion of Merck's common stock for its treasury. The treasury stock purchase has no time limit and will be made over time on the open market, in block transactions or in privately negotiated transactions.

27 Apr 2011

ProtoKinetix, Imaginative Research Associates partner to formulate topical anti-inflammation product

ProtoKinetix, is pleased to announce, that it has entered into a Joint Venture Agreement with Imaginative Research Associates, Inc. to formulate a topical anti-inflammation product for the skin care market.

27 Apr 2011

Corning first quarter sales increase 24% to $1.9 billion

Corning Incorporated today announced its results for the first quarter of 2011.

27 Apr 2011

Mastech first quarter revenue increases 27% to $19.9 million

Mastech Holdings, Inc., a national provider of Information Technology and Specialized Healthcare staffing services, announced today its financial results for the first quarter ended March 31, 2011.

27 Apr 2011

Getinge Group net sales decrease 6.0% to SEK 5,241 for first quarter 2011

Getinge Group: Reporting period January - March.

27 Apr 2011

Spectranetics revenue increases 5% to $30.4 million for first quarter 2011

Spectranetics Corporation today reported financial results for the quarter ended March 31, 2011.

27 Apr 2011

Watson reports net revenue of $876.5 million for first quarter 2011

Watson Pharmaceuticals, Inc. today reported net revenue of $876.5 million for the first quarter ended March 31, 2011, compared to $856.5 million in the first quarter 2010.

27 Apr 2011

Thermo Fisher revenues increase 4% to $2.72 billion for first quarter 2011

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2011.

From Thermo Fisher Scientific Inc. 27 Apr 2011

JumpStart Ventures invests $250,000 in SPR Therapeutics

JumpStart Ventures, a nonprofit that invests in and partners with innovative, early-stage companies in Northeast Ohio, announced an investment commitment of $250,000 in SPR Therapeutics.

27 Apr 2011

Wolters Kluwer Health enters agreement to acquire Lexi-Comp

Wolters Kluwer Health, a leading provider of information and business intelligence for professionals, students and institutions in medicine, nursing, allied health and pharmacy, today announced that it has entered into an agreement to acquire Lexi-Comp, Inc., a leading global provider of drug information and clinical content for pharmacists and clinicians.

27 Apr 2011

LSP announces initial public offering of Life Sciences Fund on NYSE Euronext

LSP Advisory B.V., a group company of LSP, one of Europe's largest and most reputable specialized healthcare and biotechnology investment firms, today announced the initial public offering of the LSP Life Sciences Fund N.V. on NYSE Euronext Amsterdam.

27 Apr 2011

Karo Bio reports net loss of MSEK 47.7 for January - March 2011

Karo Bio: The January - March 2011 period in brief. Net sales amounted to MSEK 0.0.

27 Apr 2011

Sagent Pharma closes initial public offering of 5,750,000 shares of common stock

Sagent Pharmaceuticals, Inc. today announced that it has closed its previously announced initial public offering of 5,750,000 shares of its common stock at a price to the public of $16.00 per share.

27 Apr 2011

Synthes, JNJ sign merger agreement for orthopaedics business

Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.

27 Apr 2011

PPD reports net revenue of $383.2 million for first quarter 2011

PPD, Inc. today reported its financial and operating results for the first quarter ended March 31, 2011.

27 Apr 2011

QHR signs agreement to acquire EMIS assets

QHR Technologies Inc. today announced that the Company has signed an Asset Purchase Agreement ("APA") to acquire the assets of EMIS Inc. a 100% subsidiary of Egton Medical Information Systems Limited based in Leeds, UK and part of EMIS Group plc.

27 Apr 2011

Humana declares quarterly cash dividend, anticipates first quarter diluted EPS of $1.86

Humana Inc. announced today that it has realigned its business segments to more closely reflect the company's evolving business model. Effective immediately, the company will be managing and reporting its operating results using the following segments: Retail, Employer Group, and Health and Well-Being Services.

26 Apr 2011

Waters first quarter sales rise 16% to $428 million

Waters Corporation reported first quarter 2011 sales of $428 million, an increase of 16%, from sales of $368 million in the first quarter of 2010. In the quarter, foreign currency translation added 2% to sales growth.

26 Apr 2011

Amedisys net service revenue decreases 11.8% to $364.3 million

Amedisys, Inc., a leading home health and hospice company, today reported its financial results for the first quarter ended March 31, 2011 and reaffirms 2011 guidance.

26 Apr 2011

Accuray announces expiration of HSR waiting period for TomoTherapy acquisition

Accuray Incorporated, a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in connection with the previously announced acquisition of TomoTherapy Incorporated.

26 Apr 2011